Adam Idoine - Allan Wilson Centre for Molecular Ecology and Evolution, University of Auckland

基本信息

Career Trajectory

Bio

No content for now

Research Interests

Papers共 18 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

ACQUIRED MUTATIONS IN PATIENTS WITH RELAPSED/REFRACTORY CLL WHO PROGRESSED IN THE ALPINE STUDY

Jennifer R. Brown,Jessica Li,Barbara Eichhorst,Nicole Lamanna,Susan O’Brien,Constantine S. Tam,Lugui Qiu,Ruiqi Huang, Yang Shi,Adam Idoine,Tommi Salmi,Aileen Cohen,Mazyar Shadman

Blood Advances (2025)

Cited0Views0WOSBibtex

Zanubrutinib is Well Tolerated and Effective in CLL/SLL Patients Intolerant of Ibrutinib/acalabrutinib: Updated Results

Mazyar Shadman,John M Burke, Jennifer Cultrera, Habte A Yimer, Syed F Zafar,Jamal Misleh, Subramanya S Rao, Charles M Farber, Aileen Cleary Cohen,Hui Yao,Adam Idoine, Qi An, Ian W Flinn, Jeff P Sharman

Blood advances (2025)

Cited0Views0WOSBibtex

Sonrotoclax Plus Dexamethasone Was Tolerable and Demonstrated Antimyeloma Activity in Patients with Relapsed/Refractory Multiple Myeloma Harboring T(11;14)

Abel Costa,Binod Dhakal,Malin Hultcrantz,Susan Bal,Hun Chuah,Jonathan L. Kaufman,Dickran Kazandjian,Nitya Nathwani, Gordon Royle,Douglas W. Sborov,Christopher P. Venner,Huan Cheng,Adam Idoine,Amit Agarwal,Hang Quach

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2024): S36-S37

Cited0Views0Bibtex

OA-58 Sonrotoclax Plus Dexamethasone Was Tolerable and Demonstrated Antimyeloma Activity in Patients with Relapsed/Refractory Multiple Myeloma Harboring T(11; 14)

Clinical Lymphoma Myeloma and Leukemia (2024): S36-S37

Cited0Views0Bibtex

Zanubrutinib is Well Tolerated and Effective in Acalabrutinib-Intolerant Patients with B-cell Malignancies

Mazyar Shadman,Ian W. Flinn,Moshe Y. Levy,Benjamin B. Freeman, Ben Zhang,John M. Burke,Jennifer L. Cultrera,Habte A. Yimer,Edwin C. Kingsley,Charles M. Farber,James D'Olimpio, Hui Yao,Adam Idoine, Qi An,Jeff P. Sharman

Bloodno. Supplement 1 (2024): 4632-4632

Cited0Views0Bibtex

OP112 Evaluation of A Self-Administered Smart Phone-Based Application As A Wellness Measure in A Clinical Trial of Zanubrutinib

Rocco Crescenzo,Adam Idoine,Kunthel By, Keri Yang

International Journal of Technology Assessment in Health Careno. S1 (2023)

Cited0Views0Bibtex

P633: UPDATED SAFETY AND EFFICACY RESULTS OF ZANUBRUTINIB IN PATIENTS WITH B-CELL MALIGNANCIES WHO ARE INTOLERANT OF IBRUTINIB AND/OR ACALABRUTINIB

Mazyar Shadman,Moshe Levy,Ryan Porter,John M. Burke,Jennifer L. Cultrera,Jamal Misleh,Jeff P. Sharman,Syed F. Zafar,Kunthel By,Aileen Cohen,Rocco J. Crescenzo,Adam Idoine,Ian W. Flinn

HemaSphereno. S3 (2023): e70152b3-e70152b3

Cited1Views0Bibtex

Acquired Mutations in Patients (pts) with Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia (CLL) That Progressed in the ALPINE Study

Jennifer R. Brown,Jessica Li,Barbara F. Eichhorst,Nicole Lamanna,Susan M. O'Brien,Constantine S. Tam,Luqui Qiu,Vanitha Ramakrishnan,Ruiqi Huang, Yang Shi,Adam Idoine,Tommi Salmi,Aileen Cleary Cohen,Mazyar Shadman

BLOOD（2023）

Cited5Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn